656 related articles for article (PubMed ID: 27723726)
1. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
3. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
4. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Cisek K; Krochmal M; Klein J; Mischak H
Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
[TBL] [Abstract][Full Text] [Related]
5. Pharma-metabolomics in neonatology: is it a dream or a fact?
Fanos V; Barberini L; Antonucci R; Atzori L
Curr Pharm Des; 2012; 18(21):2996-3006. PubMed ID: 22564294
[TBL] [Abstract][Full Text] [Related]
6. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
7. Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study.
Mercier K; McRitchie S; Pathmasiri W; Novokhatny A; Koralkar R; Askenazi D; Brophy PD; Sumner S
Pediatr Nephrol; 2017 Jan; 32(1):151-161. PubMed ID: 27435284
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application.
Al-Ismaili Z; Palijan A; Zappitelli M
Pediatr Nephrol; 2011 Jan; 26(1):29-40. PubMed ID: 20623143
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
10. What did we learn from multiple omics studies in asthma?
Ivanova O; Richards LB; Vijverberg SJ; Neerincx AH; Sinha A; Sterk PJ; Maitland-van der Zee AH
Allergy; 2019 Nov; 74(11):2129-2145. PubMed ID: 31004501
[TBL] [Abstract][Full Text] [Related]
11. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in neonatology: the new "omics" of bronchopulmonary dysplasia.
Piersigilli F; Bhandari V
J Matern Fetal Neonatal Med; 2016; 29(11):1758-64. PubMed ID: 26135768
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
[TBL] [Abstract][Full Text] [Related]
14. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
15. Neonatal acute kidney injury: recording rate, course, and outcome: one center experience.
Cleper R; Shavit I; Blumenthal D; Reisman L; Pomeranz G; Haham A; Friedman S; Goldiner I; Mandel D
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3379-3385. PubMed ID: 29635946
[No Abstract] [Full Text] [Related]
16. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
Castro-Santos P; Laborde CM; Díaz-Peña R
Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
[TBL] [Abstract][Full Text] [Related]
17. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
18. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
19. Omics sciences and precision medicine in melanoma.
Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
[TBL] [Abstract][Full Text] [Related]
20. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
